Teva Pharmaceutical Industries Ltd. - Company & Market Research Reports

Home /
Companies /
Teva Pharmaceutical Industries Ltd.

Teva Pharmaceuticals develops, manufactures, markets, and distributes generic medicines and a portfolio of specialty medicines worldwide. The company has a portfolio of more than 1,000 molecules, producing approximately 64 billion tablets and capsules a year at 66 manufacturing facilities. It currently ranks among the 10 top pharmaceutical companies in the world and is active in 60 countries. Founded in 1901, and based in Israel, Teva employs approximately 58,000 people around the world.

REFINE BY

KEYWORD

CATEGORIES

Central Nervous System Drugs 314
Infectious Diseases Drugs 200
Cardiovascular Drugs 199
Oncology Drugs 174
Respiratory Drugs 169
Analgesics 168
Immune Disorders Drugs 164
Musculoskeletal Disorders Drugs 161
Gastrointestinal Drugs 146
Infusions and Injectables 135
Endocrine and Metabolic Disorders Drugs 135
Sexual and Reproductive Health Drugs 131
Generic Drugs 112
Antibiotics 103
Over the Counter (OTC) Drugs 98
Pharmaceuticals 94
Drug Delivery 72
Urological Disorders Drugs 69
Inhalers and Nebulisers 66
Pharmaceutical Intermediates 60
Biopharmaceuticals 60
Mental Disorders Drugs 59
Dermatological Drugs 58
Animal Pharmaceuticals 57
Biosimilars and Biosuperiors 56
Transdermal and Transmucosal Drug Delivery 54
Leukemia Drugs 52
Hematological Drugs 52
Liver and Kidney Disorders Drugs 51
Asthma Drugs 49
Lung Cancer Drugs 48
Optical Disorders Drugs 47
Breast Cancer Drugs 45
Clinical Trials 40
Drug Discovery 37
Allergy Drugs 35
Addiction Disorders Drugs 33
Immunosuppressive Drugs 33
Anxiety Drugs 31
Anesthetic Drugs 30
Diabetes Drugs 29
Ovarian Cancer Drugs 28
Pancreatic Cancer Drugs 28
Bronchitis Drugs 28
Acne Drugs 27
Pharmaceutical Manufacturing 27
Psoriasis Drugs 26
Drugs by Therapeutic Area 25
Prostate Cancer Drugs 24
Cough and Cold Drugs 24
HIV/AIDS Drugs 24
Lymphoma Drugs 23
Brain Cancer Drugs 23
Thyroid Cancer Drugs 22
Vitamins and Dietary Supplements 22
Alzheimer's Disease Drugs 22
Skin Cancer Drugs 21
Schizophrenia Drugs 20
Colon Cancer Drugs 18
Liver Cancer Drugs 16
Bladder Cancer Drugs 16
Kidney Cancer Drugs 15
Cervical Cancer Drugs 11
Anti-Obesity Drugs 9
Vaccines 8
Company Reports 4
Uterine Cancer Drugs 4
Pharmacoeconomics 1
Cancer Vaccines 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

3,034 Results (Page 75 of 152)
- Relevance
  Sort by

Antibody Therapeutics Market by Format (Monoclonal, Polyclonal, Antibody Fragment, Bispecific), Disease Area (Oncology, Autoimmune & Inflammatory, Neurology, Hematology, Infectious), Source (Human, Chimeric), Route (IV, SC) and Region - Forecast to 2028

 Report
December 2023
307 Pages
Global

From

€4366EUR$4,950USD£3,836GBP

Acute Myeloid Leukemia - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2021 - 2029

 Report
February 2024
137 Pages
Global

From

€4190EUR$4,750USD£3,681GBP

Local Anesthesia Drugs Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3961EUR$4,490USD£3,479GBP

Darier Disease Drugs Market - Global Strategic Business Report

 Report
December 2025
172 Pages
Global

From

€5160EUR$5,850USD£4,533GBP

Hirsutism Treatment - Global Strategic Business Report

 Report
December 2025
375 Pages
Global

From

€5160EUR$5,850USD£4,533GBP

NEED HELP FINDING THE RIGHT PRODUCT? Hoseok will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Skin Rash Treatment Market - Global Strategic Business Report

 Report
December 2025
384 Pages
Global

From

€5160EUR$5,850USD£4,533GBP

Antineoplastic Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
June 2023
119 Pages
Global

From

€3500EUR$4,251USD£3,182GBP

Anti-Neoplastic Agents Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
June 2023
104 Pages
Global

From

€3500EUR$4,251USD£3,182GBP

MCL1 Inhibitor Drugs Clinical Trials & Market Opportunity Insights 2025

 Report
July 2025
80 Pages
Global

From

€2293EUR$2,600USD£2,015GBP

Biosimilars - Market Insights, Competitive Landscape, and Market Forecast - 2030

 Report
July 2024
100 Pages
Global

From

€2646EUR$3,000USD£2,325GBP

€3308EUR$3,750USD£2,906GBP

Acute Myeloid Leukemia Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3961EUR$4,490USD£3,479GBP

Myelodysplastic Syndrome Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3961EUR$4,490USD£3,479GBP

Targeted Cancer Drug Global Market Insights 2023, Analysis and Forecast to 2028, by Market Participants, Regions, Technology, Application, Product Type

 Report
May 2023
122 Pages
Global

From

€3500EUR$4,251USD£3,182GBP

Carcinoid Syndrome Management Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

 Report
June 2023
96 Pages
Global

From

€3500EUR$4,251USD£3,182GBP

US General Anesthesia Drugs Market by Route of Administration (Intravenous, Inhalational) and End-user (Hospitals, Ambulatory Surgery Centers) - Forecast to 2025

 Report
February 2021
117 Pages
United States

From

€4366EUR$4,950USD£3,836GBP

Alpha 1 Antitrypsin Deficiency Treatment - Global Strategic Business Report

 Report
December 2025
196 Pages
Global

From

€5160EUR$5,850USD£4,533GBP

Pleurodynia Treatment - Global Strategic Business Report

 Report
December 2025
270 Pages
Global

From

€5160EUR$5,850USD£4,533GBP

Chronic Obstructive Pulmonary Disease (COPD) Treatment - Global Strategic Business Report

 Report
December 2025
299 Pages
Global

From

€5160EUR$5,850USD£4,533GBP

Loratadine Market - Global Strategic Business Report

 Report
December 2025
373 Pages
Global

From

€5160EUR$5,850USD£4,533GBP

Bronchiectasis Drugs Market - Global Strategic Business Report

 Report
December 2025
207 Pages
Global

From

€5160EUR$5,850USD£4,533GBP

3,034 Results (Page 75 of 152)
- 1
- 73
- 74
- 75
- 76
- 77

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.